SEO URLwww.firestrike.ai/deals/cullgen-gyre-therapeutics-acquisition-2026-3

acquisitionAnnounced · Mar 12, 2026biotechnologySource · CredibleArticle · Factual

Cullgen · Gyre Therapeutics

Gyre Therapeutics acquires Cullgen

David Najork · Founding Software Engineer

Published Apr 29, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$300M

Target

Cullgen

San Diego, California

Acquirer

Gyre Therapeutics

Full Acquisition

Status

Pending

Gyre Therapeutics agreed to acquire Cullgen. Reported deal value: $300M. Status: Pending. Sector: biotechnology. Target headquarters context: San Diego, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-12. Figures and status may change as filings and press coverage update.

Gyre Therapeutics Reports 10% Revenue Growth in Full - Year 2025 and Announces Acquisition of Cullgen Posted: an hour ago / March 12, 2026 10:11 a.m. UTC Gyre Therapeutics reports 2025 revenue growth, plans acquisition of Cullgen , and anticipates pivotal 2026 with regulatory submissions

Deal timeline

Announced

Mar 12, 2026 · quiverquant.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in biotechnology with a reported deal value of $300M. Figures and status may change as sources update.

Sources: quiverquant.com · Primary article · FireStrike proprietary index